Rab33A: Characterization, expression, and suppression by epigenetic modification

被引:20
作者
Cheng, Elaine
Trombetta, Sergio E.
Kovacs, Daniela
Beech, Robert D.
Ariyan, Stephan
Reyes-Mugica, Miguel
McNiff, Jennifer M.
Narayan, Deepak
Kluger, Harriet M.
Picardo, Mauro
Halaban, Ruth
机构
[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[4] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06510 USA
[5] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[6] Yale Univ, Sch Med, Sect Med Oncol, Ctr Comprehens Canc, New Haven, CT 06510 USA
[7] IRCCS, Ist Dermatol San Gallicano, Rome, Italy
关键词
D O I
10.1038/sj.jid.5700386
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Rab33A, a member of the small GTPase superfamily, is an X-linked gene that is expressed in brain, lymphocytes, and normal melanocytes, but is downregulated in melanoma cells. We demonstrate that in normal melanocytes Rab33A colocalizes with melanosomal proteins and that a constitutively active GTPase mutant suppresses their transport to the melanosomes. In the brain, Rab33A is present throughout the cortex, as well as in the hippocampal CA fields. A survey of melanocytic lesions demonstrated that aberrant downregulation of Rab33A is an early event that is already prevalent in melanocytes of giant congenital nevi. Analyses of bisulfite-modified DNA revealed that Rab33A is regulated by DNA methylation of a specific promoter region proximal to the transcription initiation site, and that suppression of Rab33A in melanoma cells recapitulates normal processes that control silencing of X-linked genes, but not tissue specific gene expression. This information is important for understanding carcinogenesis as well as other aberrant processes because Rab33A may have an important role in disorders involving X-chromosome-linked genes associated with vesicular transport.
引用
收藏
页码:2257 / 2271
页数:15
相关论文
共 52 条
[1]  
Ballestar E, 2005, PROG MOLEC, V38, P169
[2]   Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger [J].
Ballestar, E ;
Esteller, M .
BIOCHEMISTRY AND CELL BIOLOGY, 2005, 83 (03) :374-384
[3]   Genetics of psychiatric disease [J].
Berrettini, WH .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :465-479
[4]   DNA methylation patterns and epigenetic memory [J].
Bird, A .
GENES & DEVELOPMENT, 2002, 16 (01) :6-21
[5]   Inactivation of tumor suppressor genes - Choice between genetic and epigenetic routes [J].
Chen, WY ;
Baylin, SB .
CELL CYCLE, 2005, 4 (01) :10-12
[6]   Emerging role of RAB GTPases in cancer and human disease [J].
Cheng, KW ;
Lahad, JP ;
Gray, JW ;
Mills, GB .
CANCER RESEARCH, 2005, 65 (07) :2516-2519
[7]   The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers [J].
Cheng, KW ;
Lahad, JP ;
Kuo, WL ;
Lapuk, A ;
Yamada, K ;
Auersperg, N ;
Liu, JS ;
Smith-McCune, K ;
Lu, KH ;
Fishman, D ;
Gray, JW ;
Mills, GB .
NATURE MEDICINE, 2004, 10 (11) :1251-1256
[8]   Methylation matters [J].
Costello, JF ;
Plass, C .
JOURNAL OF MEDICAL GENETICS, 2001, 38 (05) :285-303
[9]   Mutations in GDI1 are responsible for X-linked non-specific mental retardation [J].
D'Adamo, P ;
Menegon, A ;
Lo Nigro, C ;
Grasso, M ;
Gulisano, M ;
Tamanini, F ;
Bienvenu, T ;
Gedeon, AK ;
Oostra, B ;
Wu, SK ;
Tandon, A ;
Valtorta, F ;
Balch, WE ;
Chelly, J ;
Toniolo, D .
NATURE GENETICS, 1998, 19 (02) :134-139
[10]   Regulation of membrane transport by rab GTPases [J].
Deneka, M ;
Neeft, M ;
van der Sluijs, P .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 38 (02) :121-142